Car@PLGA-NPs target gut microbiota-ER stress axis to combat diabetes
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1667023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Wei Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Endoplasmic Reticulum Stress, Cymenes, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Previous studies have demonstrated that carvacrol (Car) ameliorates vascular and hepatic injury in db/db mice, but its low bioavailability limits clinical translation.
Methods
To address this, this study constructed carvacrol-loaded polymeric nanoparticles (Car@PLGA-NPs) to enhance carvacrol bioavailability and fully explore its novel mechanisms of action on islet function and gut homeostasis in a diabetic model. We used C57BL/6J db/db mice to measure serum fasting blood glucose, oral glucose tolerance (OGTT), insulin tolerance (ITT), and lipid profiles. Fecal samples were collected for 16S rRNA sequencing to analyze gut microbiota composition and its correlation with host indices. Pancreatic and intestinal tissues underwent histopathological staining, immunofluorescence, and Western blotting to detect endoplasmic reticulum (ER) stress-related protein expression levels (p-IRE1α, XBP1S, PERK, p-ElF2α).
Results
Results demonstrated that Car@PLGA-NPs, compared to free carvacrol, significantly improved insulin sensitivity, reduced fasting blood glucose, ameliorated dyslipidemia, attenuated inflammation, and mitigated oxidative stress in db/db mice. 16S rRNA sequencing revealed that Car@PLGA-NPs remodeled the gut microbiota composition, with Alloprevotella abundance showing a negative correlation with colonic ER stress proteins (p-IRE1α and p-ElF2α). Immunofluorescence and Western blotting further confirmed that Car@PLGA-NPs significantly suppressed the expression of ER stress-related proteins (p-IRE1α, XBP1S, PERK, p-ElF2α) in both islet and colonic tissues, demonstrating superior efficacy to free carvacrol.
Conclusions
Collectively, this study confirms that the PLGA nanocarrier effectively enhances carvacrol bioavailability. Car@PLGA-NPs improve islet function and intestinal homeostasis in diabetic mice by remodeling the gut microbiota and subsequently inhibiting ER stress in pancreatic and intestinal tissues, providing a novel nano-drug delivery system and a “microbiota-ER stress” regulatory axis for diabetes treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
- Department of Preventive Health Care, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
- The Second Clinical Medical School of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
- Clinical Laboratory, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
- Department of Pathology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
- Department of Traditional Chinese Medicine Diagnostic Studies, School of basic medicine. Guizhou University of Traditional Chinese Medicine, Guizhou, Guiyang, China.
Zitieren
APA
Zhao, W., Chen, L., Qing, J., Zhao, Z., Xiong, L., Tong, P., Huang, Z., & Chen, Y. (2026). Car@PLGA-NPs target gut microbiota-ER stress axis to combat diabetes. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1667023
Vancouver
Zhao W, Chen L, Qing J, Zhao Z, Xiong L, Tong P, et al. Car@PLGA-NPs target gut microbiota-ER stress axis to combat diabetes. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1667023
BibTeX
@article{Zhao2026,
author = {Zhao, Wei and Chen, Li and Qing, Jing and Zhao, Zhujia and Xiong, Lijuan and Tong, Pingzhen and Huang, Ziruo and Chen, Yunzhi},
title = {Car@PLGA-NPs target gut microbiota-ER stress axis to combat diabetes},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1667023}
}
EUVIMED